Soleno Therapeutics, Inc. (SLNO) at a glance

Soleno Therapeutics, Inc. (SLNO) is a company. It trades at $53.01. It does not pay a dividend. Vestovix scores it 49/100 overall. Its strongest dimension is Safety (60/100) and its weakest is Income (40/100).

Price

$53.01

Market cap

n/a

P/E ratio

n/a

Dividend yield

None

Beta

n/a

52-week range

$29.43 to $90.32